morning welcome scientific second quarter conference call operator instruction would like introduce moderator call vice president investor relation begin call vice president investor morning thank join call today chairman president chief executive officer senior vice president chief financial officer please note call webcast live archive investor section website thermofisher head news event copy press release second quarter earn available investor section website head financials begin briefly cover safe harbor statement various remark make company future expectation plan prospect constitute forward look statement purpose safe harbor provision private security litigation reform actual result differ materially indicate forward look statement result various important factor include discuss company recent annual report form subsequent quarterly report form file available investor section website head financials file elect update forward look statement point future specifically disclaim obligation even estimate change therefore know rely forward look statement represent view date subsequent today also call refer certain financial measure prepare accordance generally accept account principle reconciliation financial measure directly comparable measure available press release second quarter earn also investor section website head financials turn call chairman president chief executive good morning everyone thank join today second quarter call press release execute growth strategy deliver another fantastic quarter excellent growth bottom line reflect first half year three thing stand first exceptional execution operate speed scale deliver growth strategy gain share second already benefit accelerate investment initiate third power business system enable performance three factor position exceptionally deliver fantastic provide terrific momentum enter cover topic depth remark first recap financials revenue grow year year billion adjust operate income second quarter increase billion adjust operate margin expand basis point quarter finally deliver another quarter exceptional adjust performance achieve increase share turn market continue excellent condition drive three factor robust fundamental life science strong economic activity globally role industry play pandemic response unique competitive position excellent execution allow gain share deliver another outstanding quarter start pharma biotech outstanding performance growth drive strong underlie market condition benefit unique customer value proposition lead role support customer across wide range excite therapeutic area include significant role vaccine therapy excellent growth across business serve customer include bioproduction pharma service bioscience chromatography mass spectrometry research safety market channel clearly benefit trust partner status earn many year customer academic government grow quarter strong growth across business support customer base especially bioscience electron microscopy research safety market channel turn industrial apply grow approximately quarter continue execute high level capture opportunity particularly strong growth electron microscopy chromatography mass spectrometry business finally diagnostics healthcare grow high teen quarter customer demand base business approach prepandemic level immunodiagnostics transplant diagnostics business deliver outstanding growth also diagnostics healthcare demand test relate product grow approximately billion wrap market recap quick comment role pandemic response since begin pandemic play largest role life science tool diagnostics industry support societal response deliver critical solution customer government around world second quarter generate total billion bring first half response revenue billion benefit response activity ability give accelerate investment position company phenomenal future know addition capacity capability product make also continue invest colleague build investment last year provide nonexecutive colleague special recognition payment week additional reflect incredible contribution success many measure take ensure remain employer choice across life science industry turn great progress make growth strategy base three pillar launch high impact innovative product leverage scale high growth emerge market deliver unique value proposition customer give example start innovation launch number product across business strengthen industry leadership enable customer accelerate scientific breakthrough highlight chromatography mass spectrometry launch scientific mass spectrometer extend impact industry lead platform accelerate small molecule analysis complex compound electron microscopy business introduce scientific wafer scan electron microscope important tool help semiconductor customer efficiently ramp production smaller complex microprocessor memory device bioscience business launch several product include instrument advance cell analysis sorter powerful cell sorter tool base technology acquire propel flow offer enhance image capability enable cell therapy developer better understand cell biology turn second pillar growth strategy continue leverage scale create outstanding experience customer high growth emerge market contribute excellent growth share gain deliver across pacific cover couple highlight deliver strong growth quarter ramp single technology facility demonstrate speed scale genetic science facility ship million test support country response pandemic also contribute million urgently need product donation help bring crisis control performance across region demonstrate create differentiate experience customer significant investment make market fuel growth third pillar growth strategy customer value proposition continue increase capability capacity even better partner customer help achieve goal build significant investment last year execute billion capex expand capacity capability excite continue progress investment example quarter bring additional capacity online around world support customer production vaccine therapy include sterile fill finish line north expand single technology capacity facility site production essential material make vaccine investment value proposition demonstrate commitment customer rely essential partner work quarter announce number collaboration lead academic medical center combination innovation unique customer value proposition position move science forward example collaborate clinic develop precise personalize diagnostics blood base cancer allergy autoimmunity therapeutic drug monitor work leverage insight technology clinical next sequence immunology clinical mass spectrometry addition announce build operate state cell therapy development manufacture collaboration center university advance innovation cell gene therapy partnership lead capability customer ultimately better outcome patient always business system major factor success discipline mission drive culture help find better every continue bring innovative solution customer work efficiently effectively operate speed scale create even greater value stakeholder turn capital deployment announce acquisition begin quarter acquisition establish leader attractive high growth clinical research service industry highly complementary service fastest grow market integration plan extremely impress world class talent meet integration plan process look forward welcome colleague upon close transaction turn guidance update progress initiative world leader serve science know role beyond work enable customer value create shareholder extend responsibility make world better place continue advance sustainability initiative yesterday announce commitment achieve carbon neutrality build exist goal reduce greenhouse emission across operation move forward front make facility energy efficient increase renewable energy reduce waste operation also innovate across portfolio enable customer meet sustainability need align commitment business right mission enable customer make world healthier cleaner safer turn guidance drive strong start first half year confidence full year outlook raise revenue earn guidance full year assumption behind guidance cover highlight raise revenue guidance million billion represent report growth term adjust raise guidance represent growth turn call summarize takeaway outstanding execute prove growth strategy strengthen competitive position business system enable ability operate speed scale business perform extremely gain share enable deliver excellent first half result position deliver fantastic provide terrific momentum enter finally like thank colleague dedication company customer deliver another excellent quarter turn call senior vice president chief financial good morning everyone begin high level summary performance another excellent quarter grow revenue include organic growth mention growth strategy enable take share strong market condition result able deliver organic growth base business continue industry lead response pandemic generate billion response revenue quarter business system enable generate excellent pull strong line growth also enable execute really significant growth investment result grow adjust deliver billion free cash flow overall another excellent quarter provide color performance quarter last year line report revenue grow year year component report revenue increase include organic growth acquisition tailwind approximately foreign exchange mention base business organic growth turn performance geography quarter north grow grow pacific grow rest world grow double digit turn operational performance adjust operate income increase adjust operate margin basis point higher last year quarter business system enable deliver strong contribution volume productivity also favorable business partially offset ongoing strategic investment across business support near long term growth include investment quarter million supplementary cash bonus nonexecutive colleague record similar amount recognize extraordinary work colleague continue customer community shareholder ongoing investment colleague capacity capability ensure really bright future company move detail total company adjust gross margin quarter come flat prior year quarter deliver strong productivity positive business offset strategic investment adjust quarter revenue decrease basis point versus reflect strong volume leverage total expense approximately million represent growth versus reflect increase investment high impact innovation fuel future growth look result line quarter interest expense million million lower last year largely lower debt adjust income expense income quarter million million lower mainly change nonoperating adjust rate quarter basis point versus last year increase profit average dilute share million million lower year year drive share repurchase option dilution turn cash flow balance sheet cash flow performance enable business system strong first half year year date cash flow continue operation billion period last year year date free cash flow billion period last year invest billion capital expenditure reflect strong return generate short term investment make long term return million shareholder dividend quarter reflect dividend increase announce billion cash billion total debt leverage ratio quarter time gross debt adjust time debt basis conclude comment total company performance adjust percentage point last year continue generate exceptional return provide color performance four business segment similar last quarter start frame think impact response segment result revenue standpoint case last three quarter majority response revenue recognize life science solution remainder recognize laboratory product service specialty diagnostics margin standpoint impact differ across segment base scale response revenue different level profitability revenue addition quarter continue make strategic investment across business size investment necessarily align response revenue segment skew report segment margin move segment detail start life science solution report revenue segment increase organic growth quarter deliver exceptionally strong growth bioscience bioproduction business adjust operate income life science solution increase adjust operate margin basis point year year quarter drive strong volume pull positive business partially offset strategic investment also tailwind margin segment analytical instrument segment report revenue increase organic growth quarter excellent growth business within segment adjust operate income analytical instrument increase adjust operate margin basis point year year quarter drive strong volume pull productivity offset strategic investment make across segment turn specialty diagnostics report revenue segment increase organic growth deliver exceptionally strong growth immunodiagnostics transplant diagnostics business adjust operate income increase quarter adjust operate margin basis point prior year positive volume leverage favorable business offset continue strategic investment segment finally laboratory product service segment report revenue increase organic growth quarter excellent growth business segment adjust operate income segment increase adjust operate margin basis point higher prior year quarter deliver positive volume leverage favorable business partially offset strategic investment turn update guidance mention raise revenue adjust guidance reflect strength performance along stronger outlook base business second half year term revenue raise full year guidance million billion increase full year organic growth increase revenue guidance drive three factor increase base business organic growth outlook full year update assumption billion response revenue slightly favorable tailwind previously assume give additional detail factor start base business increase outlook million reflect great performance stronger outlook growth second half year increase full year organic growth outlook base business basis point market strong execute growth strategy increase strategic investment drive excellent performance move response revenue role support vaccine therapy continue increase expect billion relate revenue million prior guide approximately half billion recognize first half year give strength base business growth vaccine therapy response take opportunity revise guidance significantly derisk outlook test lower full year test relate response revenue million prior guidance assume billion billion deliver first half year leave billion second half continue wide range outcome test second half year scenario pandemic could increase intensity drive higher need test case position support customer need flow benefit think prudent take opportunity derisk outlook third final element revenue guidance raise rate continue fluctuate favorable prior guidance moderate significantly result increase revenue tailwind year assume million million versus prior guidance take account different margin profile revenue change outline increase annual adjust guidance result growth revenue assume guide estimate adjust operate margin full year would approximately line element guidance remain prior guide remind assumption include operational benefit acquisition clarity actual close date provide estimate potential impact expect interest expense approximately million reminder include within number million adjust placeholder prefinancing transaction expect adjust income rate assume capital expenditure approximately billion billion free cash flow approximately billion guidance still include billion capital deployment billion share buyback complete billion complete million capital return shareholder dividend estimate full year average dilute share count million share finally want touch phase revenue dollar adjust remainder year think split second half assume result slightly weight think split remember placeholder finance conclude deliver another excellent quarter great position achieve goal move second half year turn call back vice president investor operator ready take question